Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes.
Betacoronavirus
COVID-19
Coronavirus Infections
/ drug therapy
Diterpenes
/ chemical synthesis
Drug Design
Gene Expression Regulation
/ drug effects
HEK293 Cells
Humans
Inhibitory Concentration 50
Molecular Structure
Pandemics
Pneumonia, Viral
/ drug therapy
SARS-CoV-2
Structure-Activity Relationship
TRPV Cation Channels
/ antagonists & inhibitors
COVID-19
SARS-CoV-2
TRPV4 channel
amides/esters
bioactive diterpenes
labdane scaffold
sclareolide
structure-activity relationships
Journal
Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729
Informations de publication
Date de publication:
18 Oct 2020
18 Oct 2020
Historique:
received:
03
09
2020
revised:
12
10
2020
accepted:
14
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
29
10
2020
Statut:
epublish
Résumé
Labdane diterpenes are widespread classes of natural compounds present in variety of marine and terrestrial organisms and plants. Many of them represents "natural libraries" of compounds with interesting biological activities due to differently functionalized drimane nucleus exploitable for potential pharmacological applications. The transient receptor potential channel subfamily V member 4 (TRPV4) channel has recently emerged as a pharmacological target for several respiratory diseases, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Inspired by the labdane-like bicyclic core, a series of homodrimane-derived esters and amides was designed and synthesized by modifying the flexible tail in position 1 of (+)-sclareolide, an oxidized derivative of the bioactive labdane-type diterpene sclareol. The potency and selectivity towards rTRPV4 and hTRPV1 receptors were assessed by calcium influx cellular assays. Molecular determinants critical for eliciting TRPV4 antagonism were identified by structure-activity relationships. Among the selective TRPV4 antagonists identified, compound
Identifiants
pubmed: 33081023
pii: md18100519
doi: 10.3390/md18100519
pmc: PMC7594054
pii:
doi:
Substances chimiques
Diterpenes
0
TRPV Cation Channels
0
TRPV4 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca (Rome)
ID : Dipartimento di Eccellenza grant 2018-2022
Références
Nat Cell Biol. 2000 Oct;2(10):695-702
pubmed: 11025659
J Pharmacol Exp Ther. 2008 Aug;326(2):432-42
pubmed: 18499743
J Nat Prod. 2018 Dec 28;81(12):2605-2611
pubmed: 30507122
J Am Chem Soc. 2012 May 23;134(20):8432-5
pubmed: 22583115
Cell. 2000 Oct 27;103(3):525-35
pubmed: 11081638
Nat Struct Mol Biol. 2018 Mar;25(3):252-260
pubmed: 29483651
Bioorg Med Chem Lett. 2018 Apr 1;28(6):993-996
pubmed: 29501395
Planta Med. 1999 Feb;65(1):2-8
pubmed: 10083836
J Nat Prod. 2005 May;68(5):653-8
pubmed: 15921404
Curr Top Med Chem. 2011;11(17):2216-26
pubmed: 21671873
Eur J Med Chem. 2017 Aug 18;136:114-121
pubmed: 28486209
J Biol Chem. 2006 Oct 6;281(40):29897-904
pubmed: 16899456
ACS Chem Neurosci. 2014 Nov 19;5(11):1117-30
pubmed: 24926802
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1239-L1243
pubmed: 32401673
BMC Plant Biol. 2012 Jul 26;12:119
pubmed: 22834731
J Asian Nat Prod Res. 2020 May;22(5):464-473
pubmed: 31738086
ACS Chem Neurosci. 2016 Jun 15;7(6):737-48
pubmed: 26942555
Curr Med Chem. 2020;27(9):1501-1514
pubmed: 30027844
Bioorg Med Chem Lett. 2020 Apr 15;30(8):127022
pubmed: 32063431
ACS Med Chem Lett. 2013 Jan 27;4(2):293-6
pubmed: 24900661
ChemMedChem. 2016 Aug 19;11(16):1686-94
pubmed: 27240888
Am J Respir Cell Mol Biol. 2008 Apr;38(4):386-92
pubmed: 17962608
ACS Med Chem Lett. 2017 Mar 20;8(5):549-554
pubmed: 28523109
Molecules. 2020 Mar 03;25(5):
pubmed: 32138197